MedTrace Logo

Metabolic Derangements in Acute Heart Failure Syndrome

NCT00682175 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2009-03-26

No results posted yet for this study

Summary

To determine the association of both neurohormonal and hemodynamic alterations associated with metabolic abnormalities in acute heart failure syndrome.

Conditions

  • Congestive Heart Failure

Interventions

OTHER

Observational

Pulmonary Artery pressure (PA), pulmonary capillary wedge pressure (PCWP), cardiac output (CO), and cardiac index (CI). This data will be collected after 24 ± 2 and 48 ± 2 hours of standard heart failure therapy

Sponsors & Collaborators

  • The Cleveland Clinic

    lead OTHER

Principal Investigators

  • George Sokos, MD · The Cleveland Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-05-31
Primary Completion
2009-03-31
Completion
2009-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00682175 on ClinicalTrials.gov